Stockscreener 앱 받기
47.97
0.50%
-0.24
시간 외 거래:
48.46
0.49
+1.02%
Bio Techne Corp 주식(TECH)의 최신 뉴스
Bio-Techne stock hits 52-week low at 46.04 USD By Investing.com - Investing.com Nigeria
Are Wall Street Analysts Bullish on Bio-Techne Stock? - inkl
Bio-Techne Corp (TECH) Stock Analysis: An Investor's Look At 27% Potential Upside - DirectorsTalk Interviews
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
Bio-Techne Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Bio-Techne Corp (TECH) Stock Analysis: Unlocking a 41.84% Upside Potential in Healthcare Innovation - DirectorsTalk Interviews
The 5 Most Interesting Analyst Questions From Bio-Techne’s Q1 Earnings Call - Yahoo Finance
Bio-Techne stock hits 52-week low at 44.09 USD - Investing.com India
Bio-Techne stock hits 52-week low at 44.09 USD By Investing.com - Investing.com Australia
Bio-Techne Corp. stock underperforms Friday when compared to competitors - MarketWatch
RBC Capital Mkts resumed coverage on Bio-Techne with a new price target - Quantisnow
Bio-Techne (TECH) Coverage Reinitiated with Positive Outlook - GuruFocus
RBC Capital assumes Bio-Techne stock coverage with outperform rating By Investing.com - Investing.com Australia
RBC Capital assumes Bio-Techne stock coverage with outperform rating - Investing.com UK
Baron Asset Fund Sold Bio-Techne Corporation (TECH) Due to Concerns Over Potential Impact of AI - Yahoo Finance
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MSN
There May Be Some Bright Spots In Bio-Techne's (NASDAQ:TECH) Earnings - Yahoo Finance
TECH Stock Price, Quote & Chart | BIO-TECHNE CORP (NASDAQ:TECH) - ChartMill
Bio-Techne (TECH) director’s linked account exercises options and sells 6,636 shares - Stock Titan
Earnings call transcript: Bio-Techne Q3 2026 misses EPS and revenue targets By Investing.com - Investing.com South Africa
Earnings call transcript: Bio-Techne Q3 2026 misses EPS and revenue targets - Investing.com Nigeria
How Bio-Techne is bridging cancer research, spatial biology, and diagnostics - SelectScience
Bio-Techne Corp. stock underperforms Monday when compared to competitors - MarketWatch
Nicholas Company Inc. Acquires 23,785 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp (TECH) Stock Analysis: Exploring a 29.52% Potential Upside Amidst Market Volatility - DirectorsTalk Interviews
Bio-Techne(TECH) Stock Options Chain | Quotes & News - Moomoo
BIO-TECHNE CORPORATION CMNRo Khanna Congressional Trade on Apr. 13, 2026 - Quiver Quantitative
Responsive Playbooks and the TECH Inflection - Stock Traders Daily
Principal Financial Group Inc. Has $41.37 Million Stock Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp (NASDAQ:TECH) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
TECH (TECH) Form 144 shows planned option-exercise sales, prior sale by Molho - Stock Titan
Earnings call transcript: Bio-Techne Q3 2026 results show strategic focus - Investing.com UK
Earnings call transcript: Bio-Techne Q3 2026 results show strategic focus By Investing.com - Investing.com South Africa
Rep. April McClain Delaney Sells Bio-Techne Corp (NASDAQ:TECH) Shares - MarketBeat
April McClain Delaney Makes Significant Trades in Bio-Techne Corp, C.H. Robinson Worldwide, and Transdigm Group - Investing.com UK
Evercore Maintains Bio-Techne(TECH.US) With Hold Rating, Cuts Target Price to $50 - Moomoo
TECH Maintained by Evercore ISI Group -- Price Target Lowered to $50 - GuruFocus
CFO at Bio-Techne (TECH) exercises 62,000 options and settles taxes in shares - Stock Titan
Bio-Techne (TECH) SVP exercises 8,400 options, 7,055 shares withheld for taxes - Stock Titan
Bio-Techne (TECH) CEO exercises options; shares withheld for taxes - Stock Titan
Citigroup Issues Pessimistic Forecast for Bio-Techne (NASDAQ:TECH) Stock Price - MarketBeat
0.98%
0.12%
자본화:
|
볼륨(24시간):